Apolipoprotein E promoter and α2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease

Neuroscience Letters

Volumn 269, Issue 3, 1999, Pages 173-177

  Chen, Lan ^a   Baum, Larry ^a   Ng, Ho Keung ^a   Chan, Lisa Y S ^a   Sastre, Isabel ^b   Artíga, María Jesús ^b   Valdivieso, Fernando ^b   Bullido, María Jesús ^b   Chiu, Helen F K ^a   Pang, Chi Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

2 Macroglobulin polymorphism; 491 A T polymorphism; Alzheimer's disease; Apolipoprotein E; Linkage disequilibrium

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; BASE PAIRING; CHINESE; DISEASE PREDISPOSITION; EXON; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; EXONS; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HONG KONG; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; SEQUENCE DELETION;

EID: 0033575492     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00421-8     Document Type: Article

References (17)

1. Artiga M.J., Bullido M.J., Frank A., Sastre I., Recuero M., Garcia M.A., Lendon C.L., Han S.W., Morris J.C., Vazquez J., Goate A., Valdivieso F. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum. Mol. Genet. 7:1998;1887-1892.
2. Artiga M.J., Bullido M.J., Sastre I., Recuero M., Garcia M.A., Aldudo J., Vazquez J., Valdivieso F. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 421:1998;105-108.
3. Baum L., Chen L., Ng H.K., Chan Y.S., Mak Y.T., Woo J., Chiu H.F., Pang C.P. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci. Lett. 247:1998;33-36.
4. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., Perry R., Watson B. Jr, Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:1998;357-360.
5. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 18:1998;69-71.
6. Chiu H.F., Lam L.C., Chi I., Leung T., Li S.W., Law W.T., Chung D.W., Fung H.H., Kan P.S., Lum C.M., Ng J., Lau J. Prevalence of dementia in Chinese elderly in Hong Kong. Neurology. 50:1998;1002-1009.
7. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G., Sahasrabudhe S. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA. 95:1998;3275-3280.
8. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49:1997;56-61.
9. Kontula K., Aalto-Setala K., Kuusi T., Hamalainen L., Syvanen A.C. Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing. Clin. Chem. 36:1990;2087-2092.
10. Lambert J.C., Berr C., Pasquier F., Delacourte A., Frigard B., Cottel D., Perez-Tur J., Mouroux V., Mohr M., Cecyre D., Galasko D., Lendon C., Poirier J., Hardy J., Mann D., Amouyel P., Chartier-Harlin M.C. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum. Mol. Genet. 7:1998;1511-1516.
11. Laws S.M., Taddei K., Fisher C., Clarnette R., Hallmayer J., Brooks W.S., Gandy S.E., Martins R.N. The -491 A/A polymorphism in the regulatory region of the APOE gene is associated with increased ApoE levels in Alzheimer's disease in Australia. NeuroReport. 10:1999;879-882.
12. Mak Y.T., Chiu H., Woo J., Kay R., Chan Y.S., Hui E., Sze K.H., Lum C., Kwok T., Pang C.P. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology. 46:1996;146-149.
13. Nalbantoglu J., Gilfix B.M., Bertrand P., Robitaille Y., Gauthier S., Rosenblatt D.S., Poirier J. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann. Neurol. 36:1994;889-895.
14. Ng H., Cheng Y., Poon W. Alzheimer-type of pathological changes in Chinese. J. Neurol. Sci. 145:1997;97-103.
15. Song Y.Q., Rogaeva E., Premkumar S., Brindle N., Kawarai T., Orlacchio A., Yu G., Levesque G., Nishimura M., Ikeda M., Pei Y., O'Toole C., Duara R., Barker W., Sorbi S., Freedman M., Farrer L., St. George-Hyslop P. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE. Neurosci. Lett. 250:1998;189-192.
16. Toji H., Maruyama H., Sasaki K., Nakamura S., Kawakami H. Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population. Neurosci. Lett. 259:1999;56-58.
17. Town T., Paris D., Fallin D., Duara R., Barker W., Gold M., Crawford F., Mullan M. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci. Lett. 252:1998;95-98.